Psychiatry Research: Neuroimaging
Volume 164, Issue 2 , Pages 166-171 , 30 November 2008

Positron emission tomography with fluorodeoxyglucose-F18 in an animal model of mania

  • Matthew Tyler Hougland

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, United States
    • Department of Psychology, University of Louisville School of Medicine, Louisville, KY, United States
    • ,
  • Yonglin Gao

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, United States
    • ,
  • Laura Herman

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, United States
    • ,
  • Chin K. Ng

      Affiliations

    • Department of Psychology, University of Louisville School of Medicine, Louisville, KY, United States
    • ,
  • Zhenmin Lei

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, United States
    • Department of Obstetrics and Gynecology, University of Louisville School of Medicine, Louisville, KY, United States
    • ,
  • Rif S. El-Mallakh

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, United States
    • Corresponding Author InformationCorresponding author. Mood Disorders Research Program, Department of Psychiatry, University of Louisville School of Medicine, MedCenter One, 501 E Broadway, Suite 340, Louisville, KY 40202, United States. Tel.: +1 502 852 1124; fax: +1 502 852 5098.

Received 28 April 2007 ,Revised 11 November 2007 ,Accepted 7 January 2008.

References 

  1. Al-Mousawi AH, Evans N, Ebmeier KP, Roeda D, Chaloner F, Ashcroft GW. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. British Journal of Psychiatry. 1996;169:509–516
  2. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, et al. Cerebral metabolic rates for glucose in mood disorders. Archives of General Psychiatry. 1985;42:441–447
  3. Brooks JO, Wang PW, Strong C, Sachs N, Hoblyn JC, Fenn R, et al. Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. Bipolar Disorder. 2006;8:248–254
  4. Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Journal of Affective Disorders. 1986;10:137–152
  5. Buchsbaum MS, Someya T, Wu JC, Tang CY, Bunney WE. Neuroimaging bipolar illness with positron emission tomography and magnetic resonance imaging. Psychiatric Annals. 1997;27:489–495
  6. Changaris DG, Porter L, Miller JJ, Levy RS. Des-Leu angiotensin I: biosynthesis and drinking response. Regulatory Peptides. 1988;20:273–280
  7. Chen YY, Chien CN, Lee TW, Fu YK, Kuo TS, Jaw FS. Dynamic evaluation of [18F]-FDG uptake in the rate brain by microPET imaging. Conference Proceedings of the International (IEEE) Conference of the Engineering in Medicine and Biology Society. 2004;6:4461–4464
  8. El-Mallakh RS. Lithium: Actions and Mechanisms. Washington, DC: American Psychiatric Press; 1996;
  9. El-Mallakh RS, Wyatt RJ. The Na,K-ATPase hypothesis for bipolar illness. Biological Psychiatry. 1995;37:235–244
  10. El-Mallakh RS, Harrison LT, Li R, Changaris DG, Levy RS. An animal model for mania: preliminary results. Progress in Neuropsychopharmacology and Biological Psychiatry. 1995;19:955–962
  11. El-Mallakh RS, El-Masri MA, Huff MO, Li X-P, Decker S, Levy RS. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disorders. 2003;5:362–365
  12. El Mallakh RS, Decker S, Morris M, Li X-P, Huff MO, El-Masri MA, et al. Efficacy of olanzapine and haloperidol in an animal model of mania. Progress in Neuropsychopharmacology and Biological Psychiatry. 2006;30:1261–1264
  13. Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosen H, et al. Involvement of Na(+),K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders. Biological Psychiatry. 2006;60:491–499
  14. Goodwin R, Jamison KR. Manic-depressive Illness. New York: Oxford University Press; 1990;
  15. Grider G, El-Mallakh RS, Huff MO, Buss TJR, Miller J, Valdes R. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. Journal of Affective Disorders. 1999;54:261–267
  16. Herman L, Hougland MT, El-Mallakh RS. Mimicking human bipolar ion dysregulation, models mania in rats. Neuroscience and Biobehavioral Reviews. 2007;31(6):874–881
  17. Ketter TA, Wang PW. Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies. Journal of Clinical Psychiatry. 2002;63(Suppl. 3):21–25
  18. Ketter TA, Nasrallah HA, Fagiolini A. Mood stabilizers and atypical antipsychotics: bimodal treatment for bipolar disorder. Psychopharmacology Bulletin. 2006;39:120–146
  19. Kishimoto H, Takazu O, Ohno S, Yamaguchi T, Fujita H, Kuwahara H, et al. 11C-glucose metabolism in manic and depressed patients. Psychiatry Research. 1987;22:81–88
  20. Li R, El-Mallakh RS, Harrison L, Changaris DG, Levy RS. Lithium prevents ouabain-induced behavioral changes: toward an animal model for manic-depression. Molecular Chemistry and Neuropathology. 1997;31:65–72
  21. Looney SW, El-Mallakh RS. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depression and Anxiety. 1997;5:53–65
  22. Lou M, Zhang H, Wang J, Wen SQ, Tang ZQ, Chen YZ, et al. Hyperbaric oxygen treatment attenuated the decrease in regional glucose metabolism of rats subjected to focal cerebral ischemia: a high resolution positron emission tomography study. Neuroscience. 2007;146(2):555–561
  23. Marsteller DA, Barbarich-Marsteller NC, Fowler JS, Schiffer WK, Alexoff DL, Rubins DJ, et al. Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-D-glucose cerebral uptake in rodents through time. Nuclear Medicine and Biology. 2006;33(1):71–79
  24. Piper DC, Cooper DA, Upton N. The Effect of Antimanic Drugs on the Hyperlocomotor Response to ICV Administration of Ouabain in the Rat. Presented at the Annual Meeting of the European College of Neuropsychopharmacology: Amsterdam, the Netherlands; 1996;
  25. Rose AM, Mellett BJ, Valdes R, Kleinman JE, Hermann MM, Li R, et al. Alpha2 isoform of the Na,K-ATPase is reduced in temporal cortex of bipolar individuals. Biological Psychiatry. 1998;44:892–897
  26. Ruktanochai DJ, El-Mallakh RS, Li R, Levy RS. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiology and Behavior;. 1998;63:403–406
  27. Schiffer WK, Mirrione MM, Dewey SL. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. Journal of Nuclear Medicine. 2007;48(2):277–287
  28. Shaw DM. Mineral metabolism, mania, and melancholia. British Medical Journal. 1966;2:262–267
  29. Wyss MT, Spaeth N, Biollaz G, Pahnke J, Alessi P, Trachsel E, et al. Uptake of 18F-Fluorocholine, 18F-PET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. Journal of Nuclear Medicine. 2007;48(4):608–614

PII: S0925-4927(08)00018-8

doi: 10.1016/j.pscychresns.2008.01.004

Psychiatry Research: Neuroimaging
Volume 164, Issue 2 , Pages 166-171 , 30 November 2008

Article Tools

* Image Usage & Resolution